2 of 3

35. Enhancing sepsis biomarker development: key considerations from public and private perspectives

Enhancing sepsis biomarker development: key considerations from public and private perspectives

Download here

CEUs: 2 Clinical

Average read time: 75 minutes.

Short Summary of the Article:

This article reviews the progress and challenges associated with the development and clinical implementation of sepsis biomarkers. Sepsis is a life-threatening condition where rapid and accurate diagnosis is critical for patient outcomes. The article discusses the obstacles in translating biomarker discoveries into clinical practice, including the lack of consensus on diagnostic performance, limited education on biomarker utility, and challenges in regulatory approval. The article also highlights the potential of artificial intelligence (AI) in biomarker discovery and development, emphasizing the need for a multidisciplinary approach for furthering biomarker research.

 

Learning Outcomes 

Upon completion of this activity, you should have an understanding of:

  1. The challenges involved in the development and clinical implementation of sepsis biomarkers.
  2. The role of interdisciplinary collaboration and AI in enhancing biomarker research and its application in sepsis management.
  3. The differences in biomarker needs across various phases of sepsis treatment (Emergency Department, early ICU phase, prolonged ICU phase).

 

(Max of 3 Attempts)

Ryshane Sewpersad

Please Contact Us For More Details

health and safety training

If you would like to know more about our INRAsafe Accredited Courses please contact us below